title: Specific modulation of two neuronal digitalis receptors by anaesthesia.
abstract: Three isoenzymes of digitalis receptors (alpha 1, alpha 2, alpha 3) in the brain and only one in the kidney (alpha 1) can be distinguished by their ouabain affinities and their responsiveness to sodium. Since we have reported modulations for these digitalis receptors by their fatty acid membrane environment, anaesthesics could bind on and modulate either directly these receptors or indirectly by disturbing membrane lipids. The aim of this study was to evaluate this anaesthetic action on apparent ouabain affinities and sodium dependence of cerebral and renal Na+, K(+)-ATPase isoenzymes activities. Rat brain and kidney membrane fractions with pentobarbital-induced anaesthetized state were compared to an unanaesthetized state for their (1) fatty acid composition of total membrane phospholipids, (2) responsiveness to ouabain and (3) Na+ dependence of digitalis receptors. An anaesthesia period of 10 minutes induced (1) a fatty acid modification of brain membranes and (2) a significant sensibilization to ouabain for the alpha 2 and alpha 3 isoforms of digitalis receptors (alpha 2, IC50; 8.2 +/- 0.5 x 10(-7) mol/l vs 4.5 +/- 0.2 x 10(-7) mol/l; alpha 3, IC50; 6.0 +/- 0.3 x 10(-8) mol/l vs 2.5 +/- 0.1 x 10(-8). In contrast, the ouabain affinity of the alpha 1 subunit expressed in kidney and brain membranes was unaltered. No anaesthetic effect was observed on the Na+ dependence of the alpha 1 isoenzyme in the brain (4 mmol/l) and the kidney (8 mmol/l). Pentobarbital induced a desensibilization for alpha 2-receptors (8.3 +/- 0.5 vs 16.0 +/- 1.4 mmol/l Na+) and a sensibilization for alpha 3-receptors (14.4 +/- 0.8 vs 10 +/- 1.3 mmol/l Na+). These altered properties could be related to a selective modification of the fatty acid composition and/or to the presence of a specific binding site for pentobarbital on these two neuronal digitalis receptors.
authors.affiliation: INSERM U26, Hôpital F. Widal, Paris, France.
authors.forename: A
authors.initials: A
authors.lastname: Gerbi
authors.forename: J M
authors.initials: JM
authors.lastname: Maixent
authors.forename: M
authors.initials: M
authors.lastname: Zérouga
authors.forename: I
authors.initials: I
authors.lastname: Berrebi-Bertrand
authors.forename: M
authors.initials: M
authors.lastname: Debray
authors.forename: C
authors.initials: C
authors.lastname: Chanez
authors.forename: J M
authors.initials: JM
authors.lastname: Bourre
mesh_terms: D000758:Anesthesia; D000818:Animals; D007527:Isoenzymes / Q000378:metabolism; D008297:Male; D009474:Neurons / Q000187:drug effects / Q000201:enzymology*; D010042:Ouabain / Q000378:metabolism; D010424:Pentobarbital / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar; D012964:Sodium / Q000378:metabolism; D000254:Sodium-Potassium-Exchanging ATPase / Q000187:drug effects*
chemical_list: D007527:Isoenzymes; C027082:digitalis receptor; D010042:Ouabain; D012964:Sodium; D000254:Sodium-Potassium-Exchanging ATPase; D010424:Pentobarbital